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The phytochemical investigation of Vitex pinnata led to the isolation of a mixture of steroids ȕ-sitosterol and 
stigmasterol (1a and 1b) and three known flavonoid identified as 5-hydroxy-¶-trimethoxyflavone (2), 5-
hydroxy-¶-dimethoxy-flavone (3) and 5-hydroxy-¶¶-tetramethoxyflavone (4). The structures of all 
isolated compounds were carried out by NMR and mass spectrometry. The isolated compounds were evaluated 
for their anti-infective activities against Trypanosoma brucei brucei and Mycobacterium marinum. Compound 1-
 VKRZHG PRGHUDWH DQWLWU\SDQRVRPDO DFWLYLW\ ZLWK 0,& YDOXHV RI ȝJPO   DQG ȝ0
respectively while no activity observed on anti-mycobacterial. This study is the first to report the presence of 
three flavones and their antitrypanosomal activity from V. pinnata. 
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INTRODUCTION 
 
Plants play a pivotal role in drug discovery by 
producing various types of bioactive compounds including anti-
cancer (Pezzuto, 1997), anti-diabetic (Marles and Farnsworth, 
1995), anti-inflammatory (Nam, 2006), antiviral (Mukhtar et al., 
2008) and also anti-protozoan neglected diseases drugs (Schmidt 
et al., 2012). Vitex pinnata is a woody plant which can be found 
in primary, secondary forests and savannahs. This species is 
under the genus Vitex with the family Lamiaceae (formerly was 
under family Verbenaceae). It can be found in Southeast Asia 
like in Malaysia, Indonesia, Thailand, Cambodia and Philippines 
(de Kok, 2008). Traditionally the young leaves of V. pinnata are 
used by Malay communities for antipyretic treatment and bark is 
used to treat gastric ulcer (Corner, 1951). Other previous study 
described the leaves of V. pinnata were applied on cuts and 
wounds (Ong and Nordiana, 1999). Human African 
trypanosomiasis (HAT) or sleeping sickness is one of neglected 
tropical diseases listed by World Health Organisation (WHO) 
(WHO, 2013a). It is a fatal vector-borne parasitic disease 
provoked by Trypanosoma brucei rhodesiense (T. b. 
rhodesiense) or Trypanosoma brucei gambiense (T. b. 
gambiense) DQGWUDQVPLWWHGE\WKHWVHWVHÀ\Glossina spp.). This 
infectious disease happens specifically only in rural areas of sub-
Saharan Africa (Simarro et al., 2011). Only few drugs have been 
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used to treat this disease and these include suramin, pentamidin, 
melarsoprol and eflornithine and the combination of 
nifurtomox/eflornithine. Most of the drugs are old, having been 
discovered in the 1940s and 1950s, and also have adverse effects 
on patients. For this reason, mining and developing new HAT 
drugs from natural products is still crucial and indispensable 
(Jacobs et al., 2011). Tuberculosis (TB) is an infectious disease 
and the pathogen responsible for TB is Mycobacterium 
tuberculosis. TB still remains as a public health disease and 
infected millions of people each year. According to WHO report, 
TB is a second leading cause death after the human 
immunodeficiency virus (HIV) and estimated nearly 8.6 million 
new TB cases and 1.3 million TB deaths will occur in 2012 (WHO, 
2013b). Although TB is curable, however the rise of multidrug-
resistance TB (MDR-TB) cases is very concerning which therefore 
require voluminous new anti MDR-TB drug candidates to be 
discovered to combat and eradicate this infectious diseases (WHO, 
2013b). The present study reports the chemical investigation of 
extract from V. pinnata. Previous phytochemical study revealed the 
isolation of ecdysteroids, which are pinnatasterone, 20-
hydroxyecdysone  and turkesterone  (Suksamrarn and Sommechai, 
1993). Other study reported  a new iridoid glucoside, pinnatoside 
and three known flavonoids namely viscioside, apigenin, and 
luteolin were isolated from the bark of V. pinnata (Ata et al., 
2009). In this paper the isolation of secondary metabolites and its 
anti-infective activities against T. b. brucei and M. marinum of 
isolated compounds were described.  
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MATERIALS AND METHODS 
 
General Equipment and Experimental Procedures 
The optical rotations of the compounds were measured 
on a 341 Polarimeter from PerkinElmer, Inc., USA. Analytical 
Thin Layer Chromatography (TLC) was performed on pre-coated 
TLC plates with normal silica gel 60 F254 and reverse phase TLC 
silica gel 60 RP-18 F254S (layer thickness 0.2 mm, Merck, 
Germany).  
 
Plant material 
Leaf parts of V. pinnata were collected from Marang 
Kuala Terengganu, situated approximately 500 kilometres 
northeast of Kuala Lumpur on the east coast of Peninsular 
Malaysia in September 2009. The plant was authenticated by Dr. 
Nashriyah Mat from Faculty of Bioresources and Food Industry, 
Universiti Sultan Zainal Abidin and voucher specimen was 
deposited (collection number VP 01).   
 
Extraction and Isolation 
The ground leaves of V. pinnata (1 kg) were extracted in 
a Soxhlet apparatus at 40°C by utilising three different solvents 
based on their polarity. The extraction was started with n-hexane 
followed by ethyl acetate then methanol with solvent volumes of 
7.5 L each for 72 hours.  
Later the extracts were concentrated in vacuo by using 
rotary evaporator (BUCHI Labortechnik AG, Switzerland) at 40ºC 
and the yield was 6.33g (n-hexane extract), 6.5g (ethyl acetate 
extract) and 5.2g (methanol extract). All dried extracts were stored 
at -20ºC freezer.  Fractionation of the n-hexane extract (6.33g) was 
accomplished by using Medium Pressure Liquid Chromatography 
(MPLC).  
Linear gradient elution was employed with hexane (A) 
and ethyl acetate (B) as solvents at a flow rate of 100ml/min. Pre-
packed VersaPak silica cartridge (particle size 20-ȝPGLDPHWHU
and length 40 x 150 mm) from Supelco was used in this run. 100% 
A was run for 5 min (isocratic) followed by 100% A to 100% B 
for 20 min (gradient) then with 100% B for the last 5 min 
(isocratic).  
The run time was 30 min in total. For the first and last 5 
min of the run, the fractions were collected for every 100 ml and 
followed by 50 ml volume fractions for 20 min resulting to 50 
fractions. Fractions with similar TLC profiles were pooled 
together yielding 28 fractions.  Fraction 12 contained a mixture of 
two compounds assigned as 1 (15mg).  
Fraction 13 was further subjected to MPLC over a a pre-
packed VersaPak silica cartridge (particle size 20±ȝPGLDPHWHU
and length 23 x 53 mm) utilising an isocratic gradient system with 
80% hexane and 20% ethyl acetate for 30 min at a flow rate of 20 
ml/min. Fraction 13 afforded six sub-fractions and gave one pure 
compound 2 (20 mg). Fraction 16 afforded one major compound 3 
(4 mg). Fraction 19 afforded the major compound 4 (130mg) by 
crystallisation after washing with mixtures of hexane and 
methanol.  
NMR Instrumentation 
One and two dimensional Nuclear Magnetic Resonance 
(NMR) experiments were measured in Strathclyde Institute of 
Pharmacy and Biomedical Sciences by using 400 MHz on an AS-
400 JEOL NMR instrument (Tokyo, Japan). All isolated samples 
ZHUHGLVVROYHGLQȝORIGHXWHUDWHGFKORURIRUP&'&O3). 
 
HR-LCMS analysis 
In High Resolution-Liquid Chromatography Mass 
Spectrometry (HR-LCMS) analysis, all samples were dissolved in 
MeOH HPLC grade to give final concentration of 1mg/ml. HR-
LCMS analysis was carried out using a Accela 600 High 
Performance Liquid Chromatography (HPLC) pump with Accela 
autosampler and UV/Vis detector (Thermo Scientific, Bremen, 
Germany) and Orbitrap Exactive mass spectrometer (Thermo 
Fisher Scientific Inc, Hemel Hempstead UK). A reversed phase 
silica C18 HPLC column, 75.0 x 3.0 mm2 (Hichrom Limited, UK) 
with particle size oI  ȝP SRUH VL]H  Û$ ZDV XVHG 7KH
approximate pressure was at 37 bar while the temperature was 
maintained at 22 ͼC. The mobile phase consisted of purified water 
(A) and acetonitrile (B) with 0.1 % formic acid in each solvent. 
The samples were eluted on a linear gradient of 90% A and 10% B 
to 100% B for 30 min and changed to isocratic mode for 5 min 
before decreasing back to 10% of B for 1 min. Then the column 
was re-equilibrated with 10% of B for 9 min before the next 
sample injection. The flow rate usHGLQWKLVPHWKRGZDVȝOPLQ
DQGWKHLQMHFWLRQYROXPHZDVȝO 
 
GCMS Analysis 
6DPSOH  ȝO ZDV LQMHFWHG LQWR WKH WKH *DV
Chromatography Mass Spectrometry (GCMS) (Focus GC-DSQ2) 
system from Thermo Fisher Scientific (Bremen, Germany) using 
with 30 m loQJPPLGDQGȝPILOPWKLFNQHVV,QHUW&DS
1 MS capillary column from GL Sciences (Japan). The oven 
temperature was set at 80oC for 1 minute and the temperature was 
increased at a rate of 15o/min until it reached to 200oC and was 
maintained for 15 min. Then the temperature was again increased 
at a rate of 5oC/min until the final temperature of 320oC (held for 
10 min). The base temperature of the split/splitless (SSL) was 
250oC. The mode was splitless. The split flow was on at 15 
mL/min. The splitless time was 1 minute. The carrier method was 
set to constant flow. The initial value was 1.50 mL/min and the 
initial time was 1 minute. The MS transfer line was maintained at 
a temperature of 320oC. The source temperature of the DSQ II 
mass spectrometer was set to 250oC. The mass range used was 
50.0-800.0. 
 
Anti-infective assays 
The in vitro antitrypanosomal and antimycobacterial 
activities were examined according to the standard protocols 
previously published (Viegelmann et al., 2014). 
 
RESULT AND DISCUSSION 
 
The substance 1 was observed as a white powder. From 
the GCMS result, it showed two peaks at 19:23 and 19:53 minutes 
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with the molecular ion peaks at m/z 412.51 [M]+ and 414.51 [M]+, 
respectively. Online GCMS NIST library database suggested this 
fraction is a mixture of two compounds. GCMS spectrum at m/z 
414.51 suggested the compound is ȕ-sitosterol 1a, with the 
molecular formula C29H50O while at m/z 412.51 is stigmasterol 1b 
with the molecular formula C29H48O. The HMQC spectrum was 
done to confirm the identity of the individual compounds in each 
of the mixture which were elucidated as ȕ-sitosterol and 
stigmasterol by observing the specific signals at positions C-22 
and C-23.  
In the HMQC spectrum of stigmasterol the chemical 
shifts at positions C-22 and C-23 are 138.0 and 129.2 ppm, 
respectively which suggested an alkene group while in ȕ-sitosterol, 
chemical shift signals at C-22 and C-23 were at 34.0 and 26.1 
ppm, respectively for an alkyl group. Based on comparison to 13C 
NMR data of 1a and 1b to the previous literatures (Alam et al., 
1996; Mahato and Kundu, 1994) (Table 1) supported that 
compound 1a and 1b is a mixture of ȕ-sitosterol and stigmasterol.  
 
 
Table 1: 13C NMR data of ȕ-sitosterol (1a) and stigmasterol (1b) in 
Chloroform-d 
Carbon 1a 
ȕ-sitosterol 
(Alam et al., 
1996) in 
Chloroform-d 
1b 
Stigmasterol 
(Mahato and 
Kundu, 1994) in 
Chloroform-d 
Position įC įC įC įC 
1 37.4 37.3 37.1 37.3 
2 31.9 31.9 31.6 31.7 
3 71.8 71.9 71.8 71.9 
4 42.3 42.3 41.5 42.3 
5 140.3 140.8 140.3 140.8 
6 121.7 121.8 121.7 121.8 
7 31.7 31.7 31.7 32.1 
8 32.0 32.0 32.0 32.0 
9 50.1 50.2 50.1 50.2 
10 36.5 36.6 36.7 36.6 
11 21.1 21.2 20.8 21.2 
12 39.6 39.8 39.6 39.8 
13 42.3 42.4 42.3 42.4 
14 56.7 56.8 56.7 56.8 
15 24.3 24.4 24.3 24.4 
16 28.6 28.3 28.6 28.3 
17 55.9 56.1 55.9 56.1 
18 11.6 11.9 11.6 11.9 
19 19.4 19.5 19.2 19.1 
20 36.2 36.2 40.1 40.6 
21 18.8 18.9 20.5 20.0 
22 34.0 34.0 138.0 138.4 
23 26.1 26.2 129.2 129.2 
24 45.8 46.0 51.1 51.3 
25 29.2 29.2 32.0 34.0 
26 19.8 19.9 19.0 18.9 
27 19.0 19.1 21.2 21.3 
28 23.1 23.1 25.4 25.5 
29 12.0 12.1 12.0 12.1 
 
 
Compound 2 was obtained as white needles, m.p. 427ºC. 
ESI-MS peak in the positive mode was found at m/z 329.1026 
[M+H]+ (base peak) which revealed a molecular weight of 328.32 
g/mol and a molecular formula of C18 H16 O6. Consequently, 
compound 2 had 11 degree of unsaturation. The 1H NMR spectrum 
of 2 7DEOH  GLVSOD\HG D VLQJOHW VLJQDO DW į  GXH WR WKH
strongly hydrogen bonded phenolic hydroxyl moiety. The presence 
RIWZRGRXEOHWVLJQDOVDWįH 6.44 (d, J DQGįGJ=2) were 
characteristic of two meta-related H-6 and H-8 as in a 5,7 
disubstituted A-ring flavonoid.  In the B ring system, two sets of 
V\PPHWULFSURWRQGRXEOHWVLJQDOVDWį+G J=9) and 7.02 
(2H, d, J ZHUHGHWHFWHGIRUDQ$$¶%%¶V\VWHPZKLFKLQGLFDWHG
that C-¶ ZDV VXEVWLWXWHG In addition, the 1H NMR spectrum of 
WKLV FRPSRXQG H[KLELWHG WKUHH VLQJOHWV DW įH 3.89, 3.87 and 3.85 
showing the existence of three methoxyl groups. By comparing the 
data with previous literature (Rossi et al., 1997), the compound 2 
was identified as 5-hydroxy-¶-trimethoxyflavone previously 
isolated from Aniba species.  Compound 3 was obtained as white 
needles, m.p. 381ºC. The ESI-MS spectrum showed a molecular 
ion at negative mode with m/z 297.2434 [M-H]- suggested a 
molecular formula of C19H18O7. The 1H NMR spectrum (Table 2) 
VKRZHG RI WZR PHWKR[\ VLJQDOV DW įH 3.88 and 3.89. One 
GRZQILHOG VLQJOHW DW įH 12.80 assigned to a phenolic hydroxyl 
group. The 1H NMR spectrum of compound 3 was found to be 
similar to spectrum compound 2 except that compound 3 showed 
DGGLWLRQDOVLQJOHWSHDNDWįH 6.58 suggested its position at C-3. In 
the A ring, AB system was assigned to two doublet protons (H-6 
and H-DWįH 6.37 and 6.48 with typical meta coupling constant 
of J=  2.2 Hz. In the B ring system, two sets of symmetric proton 
VLJQDOVį+G J=9) and 7.01 (2H, d, J=9) were detected for 
DQ$$¶%%¶V\VWHPZKLFKLQGLFDWHGWKDW&-¶ZDVVXEVWLWXWHG7KH
structure of 3 was identified as 5-hydroxy-¶-dimethoxyflavone 
based on comparison to the previous published data (Kolak et al., 
2009). Compound 4 was obtained as white crystalline needles, 
m.p. 473ºC. A molecular formula of C19H18O7 was deduced by 
ESI-MS with molecular ion peak at m/z 359.1134 [M+H]+ (base 
peak) with 11 degrees of unsaturation.  
 
 
 
Fig. 1: Structures of isolated secondary metabolites from V. pinnata 
 
 The 1H NMR spectrum (Table 3) showed four methoxy 
VLJQDOVDWįH 3.86, 3.88, 3.96 and 3.97. One downfield VLQJOHWDWįH 
12.64 was assigned to a phenolic hydroxyl group. In the A ring, 
AB system was assigned to two doublet protons (H-6 and H-8) at 
įH 6.36 and 6.45 with a typical meta coupling constant of J= 2.2 
Hz.  
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Compound 1a and 1b, 2, 3 and 4 showed moderate 
DQWLWU\SDQRVRPDO DFWLYLW\ ZLWK 0,& YDOXHV RI ȝJPO 
DQGȝ0+RZHYHUQRDFWLYLW\ZDVREVHUYHGLQDOOLVRODWHG
compounds against M. marinum (Table 4). Previous study reported 
that compound 4 was inactive against T. b. rhodesiense and T. 
cruzi (IC50 ! ȝ0 KRZHYHU VKRZHG DGHTXDWH DQWLOHLVPDQLDO
activity against Leishmania donovani with IC50 YDOXHRIȝ0
(Tasdemir et al., 2006).  
 
Table 4: Summary of anti-infective activities of isolated compounds from V. 
pinnata. 
Compounds 
Antitrypanosomal activity 
against T. b. brucei, MIC 
ȝ0 
Anti-mycobacterial 
activity against M. 
marinum 0,&ȝ0 
1 ȝJPO >100 
2 19.0 ± 3.5 >100 
3 21.0 ± 4.1 >100 
4 17.0 ± 2.3 >100 
Suramin 0.11 ± 0.0  
Gentamycin  13.48 ± 0.0 
 
Tumor necrosis factor-Į71)-ĮLVDJURXSRIF\WRNLQHV
that involved systemic inflammatory reaction. Previous report 
describes the level of TNF-ĮZDVLQFUHDVHGLQWKHVHUDRIEDFWHULDO
viral, and parasitic-infected patients including malaria and 
leishmaniasis (Barral-Netto et al., 1991; Scuderi et al., 1986; 
Shaffer et al., 1991).  
The level of TNF-ĮLQVHUXPRIT. b. gambiense-infected 
patient also corresponding with the disease severity (Okomo-
Assoumou et al., 1995). Other finding also reported the level of 
TNF-Į ZDV KLJK LQ SDWLHQW ZLWK ODWH-stage of T. b. gambiense 
infection and was declined dramatically after treatment with 
melarsoprol (Rhind et al., 1997). Traditionally, Malay community 
used leaves of V. pinnata to treat inflammation including fever and  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
wounds (Burkill, 1966; Ong and Nordiana, 1999) and based from 
these evidences suggested the anti-inflammatory response in 
treating fever and wounds is possibly from compound 2, 3 and 4 
which exhibited moderate antitrypanosomal activity against T. b. 
brucei.  
 
CONCLUSIONS 
 
In conclusion, this finding reported that compound 2, 3 
and 4 were isolated efficiently for the first time from V. pinnata by 
using MPLC. In this study as well reported a moderate 
antitrypanosomal activity of these compounds against T. b. brucei 
for the first time. 
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